Traverse Biotech
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
708 Greenwich St Apt 4C, New York City, ...Website
www.traversebiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Traverse Biotech
Traverse Biotech is a New York City-based immunotherapy company focused on developing next-generation, first-in-class immunotherapies. The company aims to re-arm the immune system to be part of the cure by harnessing clinically validated technologies. Traverse operates on a risk-sharing model with licensing partners, leveraging their technical and developmental expertise. Their mission is to accelerate the availability of innovative treatments worldwide for people of all ages.Explore more
Traverse Biotech Org Chart
OA
Chief Financial Officer
HA
Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Traverse Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Traverse Biotech has recently received funding, and reach out quickly before it becomes old news!
Check out if Traverse Biotech is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Traverse Biotech recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Traverse Biotech had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Traverse Biotech has new funding data
Product Launch: Get notified when Traverse Biotech launches new products
Congratulate Masked Content for being promoted to Masked Content at Traverse Biotech
Traverse Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Traverse Biotech as Masked Content
Find more new buyers
Compare Similar Companies to Traverse Biotech
Compare insights from companies similar to Traverse Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Traverse Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Traverse Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Traverse Biotech.
Traverse Biotech Tech Stack
A closer look at the technologies used by Traverse Biotech
Traverse Biotech News & Media
Traverse Biotech Awarded Phase I SBIR Grant by the National Institute of Allergy and Infectious Diseases for Development of Innate Immune Stimulator
NEW YORK, May 1, 2024 /PRNewswire/ -- Traverse Biotech, Inc. has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. This grant will support the development of our oral innate...Traverse Biotech announces a world-wide license agreement with Genmab to develop and commercialize a novel cancer bispecific antibody
This new licensing collaboration strives to accelerate the development of an immuno-oncology product for the treatment of selected cancers. NEW YORK, Sept. 12, 2023 /PRNewswire/ -- Traverse Biotech, a US-based biotechnology company focused on the development of immunotherapies from...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Traverse Biotech
Sign Up For FreeTo access detailed company insights
Traverse Biotech is a New York City-based immunotherapy company focused on developing next-generation, first-in-class immunotherapies. The company aims to re-arm the immune system to be part of the cure by harnessing clinically validated technologies. Traverse operates on a risk-sharing model with licensing partners, leveraging their technical and... Read More
